US Deputy Health Secretary Jim O'Neill, a key figure in public health, is focused on increasing human healthspan through longevity-focused research, according to an exclusive interview with MIT Technology Review earlier this month. Meanwhile, the corporate world continues to grapple with the fallout from the Jeffrey Epstein files, as boards and business leaders navigate difficult questions about executives' ties to the disgraced financier, Fortune reported. Elsewhere, the transatlantic alliance's future is being discussed at the Munich Security Conference, NPR Politics noted.
O'Neill, who oversees a department with a budget exceeding a trillion dollars, also signed the decision memorandum on the US's new vaccine schedule, MIT Technology Review reported. He holds two roles at the top of the country's federal health and science agencies.
The Epstein files, which were released by the U.S. Justice Department, have revealed the names of business elites from Hollywood to New York to Dubai who were connected to Epstein. Fortune reported that companies are now trying to determine who knew what and when, and whether executives committed crimes or simply exhibited poor judgment.
At the Munich Security Conference, U.S. Senators Jeanne Shaheen and Thom Tillis, co-chairs of the bipartisan Senate NATO Observer Group, sat down with NPR's Mary Louise Kelly to discuss the future of the transatlantic alliance.
In other news, a study suggests that moderate caffeine intake might reduce dementia risk, according to Nature News. The study examined data from 130,000 people and found a link between coffee consumption and slower brain aging.
Finally, actor Callum Turner was immediately asked about James Bond rumors at the Berlin Film Festival press conference for his new film, "Rosebush Pruning," Variety reported. Turner, whose name has been mentioned in connection with Denis Villeneuve's upcoming Bond movie, declined to comment.
Discussion
AI Experts & Community
Be the first to comment